- AWH Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Aspira Women's Health (AWH) CORRESPCorrespondence with SEC
Filed: 1 May 17, 12:00am
12117 Bee Caves Road Building Three, Suite 100
Austin, TX 78738
May 1, 2017
VIA EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attn: Ada Sarmento
Re: Registration Statement on Form S-3 (Registration No. 333-217249)
Ladies and Gentlemen:
Reference is made to the above-captioned Registration Statement initially filed by Vermillion, Inc. (the “Company”) with the U.S. Securities and Exchange Commission on April 11, 2017 (the “Registration Statement”). Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby respectfully requests that the effective date of the Registration Statement be accelerated to Thursday, May 4, 2017, at 5:00 p.m. (Eastern Time) or as soon thereafter as may be practicable.
[Signature page follows]
Please contact Beth E. Peev of Sidley Austin LLP at (312) 853-7443 with any questions regarding the foregoing and to confirm the effectiveness of the Registration Statement.
Very truly yours,
VERMILLION, INC.
By: /s/ Eric J. Schoen
Name: Eric J. Schoen
Title: Senior Vice President, Finance and
Chief Accounting Officer